UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 239

Sortiert nach

Detection of Bluetongue Virus RNA in Field-Collected Culicoides spp. (Diptera: Ceratopogonidae) Following the Discovery of Bluetongue Virus Serotype 1 in White-Tailed Deer and Cattle in Louisiana

Journal of medical entomology, 2010-03, Vol.47 (2), p.269-273

2010

Volltextzugriff (PDF)

Oncology patient-reported claims: maximising the chance for success

Ecancermedicalscience, 2011-01, Vol.5, p.212-212

2011

Volltextzugriff (PDF)

Low zinc status in rats impairs calcium uptake and aggregation of platelets stimulated by fluoride

Proceedings of the Society for Experimental Biology and Medicine, 1993-09, Vol.203 (4), p.480-484

1993

Volltextzugriff (PDF)

Impaired Hemostasis and Platelet Function in Rats Fed Low Zinc Diets Based on Egg White Protein

The Journal of nutrition, 1990-09, Vol.120 (9), p.1062-1067

1990

Volltextzugriff (PDF)

Production and Reversal of the Neuromuscular Pathology and Related Signs of Zinc Deficiency in Guinea Pigs

The Journal of nutrition, 1989-02, Vol.119 (2), p.196-201

1989

Volltextzugriff (PDF)

The impact of mode of delivery on infant neurologic outcomes in myelomeningocele

American journal of obstetrics and gynecology, 2016-10, Vol.215 (4), p.495.e1-495.e11

2016

Volltextzugriff (PDF)

North American Fetal Therapy Network: intervention vs expectant management for stage I twin-twin transfusion syndrome

American journal of obstetrics and gynecology, 2016-09, Vol.215 (3), p.346.e1-346.e7

2016

Volltextzugriff (PDF)

PSS15 COMPARISON OF THE PRO ENDPOINTS FOUND IN LABELING CLAIMS OF PRODUCTS FOR THE TREATMENT OF PSORIASIS WITH THOSE RECOMMENDED BY THE CORRESPONDING EMEA GUIDANCE

Value in health, 2010, Vol.13 (3), p.A148-A148

2010

Volltextzugriff (PDF)

PCN111 PRO LABELLING CLAIMS IN ANTINEOPLASTIC AGENTS

Value in health, 2010, Vol.13 (3), p.A45-A45

2010

Volltextzugriff (PDF)

PMC49 THE ROLE OF PATIENT-REPORTED OUTCOMES (PRO) AS PRIMARY ENDPOINTS IN THE EVALUATION OF MEDICINES APPROVED WITH PRO CLAIMS

Value in health, 2010, Vol.13 (7), p.A338-A338

2010

Volltextzugriff (PDF)

Evaluation of Myocardial Mechanics in the Fetus by Velocity Vector Imaging

Journal of the American Society of Echocardiography, 2008-05, Vol.21 (5), p.470-474

2008

Volltextzugriff (PDF)

Detection of Bluetongue Virus RNA in Field-Collected Culicoides spp. (Diptera: Ceratopogonidae) Following the Discovery of Bluetongue Virus Serotype 1 in White-Tailed Deer and Cattle in Louisiana

Journal of medical entomology, 2010-03, Vol.47 (2), p.269-273

2010

Volltextzugriff (PDF)

QL3 ACCESS TO HEALTH-RELATED QUALITY OF LIFE (HRQL) INSTRUMENTS AND THEIR TRANSLATIONS IN THE LIGHT OF EMEA RECOMMENDATIONS

Value in health, 2008, Vol.11 (6), p.A341-A341

2008

Volltextzugriff (PDF)

PMC37 ACCESS TO PATIENT-REPORTED OUTCOME (PRO) INSTRUMENTS ANDTHEIR TRANSLATIONS IN THE LIGHT OF FDA RECOMMENDATIONS

Value in health, 2008, Vol.11 (3), p.A180-A180

2008

Volltextzugriff (PDF)

PMC66 THE ADVANTAGES OF A CENTRALIZED DISSEMINATION STRATEGY FOR HEALTH OUTCOMES INSTRUMENTS AND THEIR TRANSLATIONS: A CASE EXAMPLE WITH THE ZARIT BURDEN INTERVIEW (ZBI)

Value in health, 2009, Vol.12 (7), p.A399-A399

2009

Volltextzugriff (PDF)

PMC18 USE OF PRO INSTRUMENTS: COPYRIGHT ISSUES

Value in health, 2007, Vol.10 (3), p.A189-A189

2007

Volltextzugriff (PDF)

PND12 A LITERATURE REVIEW OF PATIENT-REPORTED OUTOMES (PROS), NEUROPSYCHOLOGICAL AND COGNITIVE INSTRUMENTS IN PARKINSON'S DISEASE

Value in health, 2006-11, Vol.9 (6), p.A377-A377

2006

Volltextzugriff (PDF)

PMC48 UPDATE OF TRENDS IN THE INCLUSION OF PATIENT-REPORTED OUTCOME (PRO) DATA IN APPROVED DRUGS LABELING BY FDA AND EMEA

Value in health, 2008, Vol.11 (6), p.A574-A574

2008

Volltextzugriff (PDF)

PHP82 RECENT TRENDS IN THE INCLUSION OF PATIENT-REPORTED OUTCOME (PRO) DATA IN APPROVED DRUGS LABELING BY FDA AND EMEA

Value in health, 2008, Vol.11 (3), p.A54-A54

2008

Volltextzugriff (PDF)

PMC29 DEVELOPMENT OF A REGULATORY POST-MARKETING STUDIES DATABASE

Value in health, 2009, Vol.12 (3), p.A24-A24

2009

Volltextzugriff (PDF)

PHP85 RECOMMENDATIONS FOR THE USE OF PATIENT REPORTED OUTCOMES TO ASSESS TREATMENT EFFICACY IN CLINICAL GUIDANCE DOCUMENTS RELEASED BY THE FDA AND EMEA

Value in health, 2009, Vol.12 (7), p.A253-A253

2009

Volltextzugriff (PDF)

PCN137 ONCOLOGY PATIENT-REPORTED CLAIMS: MAXIMISING THE CHANCE FOR SUCCESS

Value in health, 2009, Vol.12 (7), p.A283-A283

2009

Volltextzugriff (PDF)

PSY41 PATIENT-REPORTED OUTCOME (PRO) LABELING CLAIMS IN PAIN TREATMENT: OVERVIEW OF US AND EUROPEAN DRUG APPROVALS

Value in health, 2009, Vol.12 (3), p.A138-A138

2009

Volltextzugriff (PDF)

PCN57 PATIENT REPORTED OUTCOMES IN LABELING FOR ONCOLOGY PRODUCTS: REVIEW OF FDA AND EMEA LABELS

Value in health, 2007, Vol.10 (3), p.A141-A141

2007

Volltextzugriff (PDF)

PND39 PATIENT-REPORTED OUTCOME (PRO) LABELING CLAIMS IN PARKINSON'S DISEASE: OVERVIEW OF US AND EUROPEAN DRUG APPROVALS

Value in health, 2007, Vol.10 (6), p.A392-A392

2007

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(206)
Mit Volltextzugriff
(226)

Publikationsform

Artikel
(224)
Buchkapitel
(11)
Bücher
(3)
Reviews
(1)

Sprache

Englisch
(239)
Japanisch
(33)

Erscheinungsjahr

n.n

Thema

Science & Technology
(145)
Life Sciences & Biomedicine
(116)
Humans
(94)
Male
(68)
Female
(65)
Biological And Medical Sciences
(63)
Medical Sciences
(53)
Middle Aged
(43)
Adult
(40)
Rheumatology
(35)
Aged
(32)
Rheumatoid Arthritis
(28)
Arthritis, Rheumatoid - Drug Therapy
(25)
Tumor Necrosis Factor-Alpha - Antagonists & Inhibitors
(23)
Antirheumatic Agents - Therapeutic Use
(22)
Diseases Of The Osteoarticular System
(22)
Internal Medicine
(22)
Physical Sciences
(21)
Tumor Necrosis Factor-Tnf
(19)
Patients
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Detection of Bluetongue Virus RNA in Field-Collected Culicoides spp. (Diptera: Ceratopogonidae) Following the Discovery of Bluetongue Virus Serotype 1 in White-Tailed Deer and Cattle in Louisiana

Oncology patient-reported claims: maximising the chance for success

Low zinc status in rats impairs calcium uptake and aggregation of platelets stimulated by fluoride

Impaired Hemostasis and Platelet Function in Rats Fed Low Zinc Diets Based on Egg White Protein

Production and Reversal of the Neuromuscular Pathology and Related Signs of Zinc Deficiency in Guinea Pigs

The impact of mode of delivery on infant neurologic outcomes in myelomeningocele

North American Fetal Therapy Network: intervention vs expectant management for stage I twin-twin transfusion syndrome

PSS15 COMPARISON OF THE PRO ENDPOINTS FOUND IN LABELING CLAIMS OF PRODUCTS FOR THE TREATMENT OF PSORIASIS WITH THOSE RECOMMENDED BY THE CORRESPONDING EMEA GUIDANCE

PCN111 PRO LABELLING CLAIMS IN ANTINEOPLASTIC AGENTS

PMC49 THE ROLE OF PATIENT-REPORTED OUTCOMES (PRO) AS PRIMARY ENDPOINTS IN THE EVALUATION OF MEDICINES APPROVED WITH PRO CLAIMS

Evaluation of Myocardial Mechanics in the Fetus by Velocity Vector Imaging

Detection of Bluetongue Virus RNA in Field-Collected Culicoides spp. (Diptera: Ceratopogonidae) Following the Discovery of Bluetongue Virus Serotype 1 in White-Tailed Deer and Cattle in Louisiana

QL3 ACCESS TO HEALTH-RELATED QUALITY OF LIFE (HRQL) INSTRUMENTS AND THEIR TRANSLATIONS IN THE LIGHT OF EMEA RECOMMENDATIONS

PMC37 ACCESS TO PATIENT-REPORTED OUTCOME (PRO) INSTRUMENTS ANDTHEIR TRANSLATIONS IN THE LIGHT OF FDA RECOMMENDATIONS

PMC66 THE ADVANTAGES OF A CENTRALIZED DISSEMINATION STRATEGY FOR HEALTH OUTCOMES INSTRUMENTS AND THEIR TRANSLATIONS: A CASE EXAMPLE WITH THE ZARIT BURDEN INTERVIEW (ZBI)

PMC18 USE OF PRO INSTRUMENTS: COPYRIGHT ISSUES

PND12 A LITERATURE REVIEW OF PATIENT-REPORTED OUTOMES (PROS), NEUROPSYCHOLOGICAL AND COGNITIVE INSTRUMENTS IN PARKINSON'S DISEASE

PMC48 UPDATE OF TRENDS IN THE INCLUSION OF PATIENT-REPORTED OUTCOME (PRO) DATA IN APPROVED DRUGS LABELING BY FDA AND EMEA

PHP82 RECENT TRENDS IN THE INCLUSION OF PATIENT-REPORTED OUTCOME (PRO) DATA IN APPROVED DRUGS LABELING BY FDA AND EMEA

PMC29 DEVELOPMENT OF A REGULATORY POST-MARKETING STUDIES DATABASE

PHP85 RECOMMENDATIONS FOR THE USE OF PATIENT REPORTED OUTCOMES TO ASSESS TREATMENT EFFICACY IN CLINICAL GUIDANCE DOCUMENTS RELEASED BY THE FDA AND EMEA

PCN137 ONCOLOGY PATIENT-REPORTED CLAIMS: MAXIMISING THE CHANCE FOR SUCCESS

PSY41 PATIENT-REPORTED OUTCOME (PRO) LABELING CLAIMS IN PAIN TREATMENT: OVERVIEW OF US AND EUROPEAN DRUG APPROVALS

PCN57 PATIENT REPORTED OUTCOMES IN LABELING FOR ONCOLOGY PRODUCTS: REVIEW OF FDA AND EMEA LABELS

PND39 PATIENT-REPORTED OUTCOME (PRO) LABELING CLAIMS IN PARKINSON'S DISEASE: OVERVIEW OF US AND EUROPEAN DRUG APPROVALS

Suchergebnisse filtern